Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Melissa G. Ooi"'
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 1013-1018 (2023)
Abstract Multiple myeloma, a hematological malignancy, imposes a significant financial burden on healthcare systems. Health technology assessments (HTA) and economic evaluations play vital roles in reimbursement decisions and cost containment. This s
Externí odkaz:
https://doaj.org/article/d07f362fe71a463ea10817ea03679cd7
Autor:
Harry Gill, Radha Raghupathy, Hsin-An Hou, Adisak Tantiworawit, Melissa G. Ooi, Priscella S. Chia, Gin Gin Gan, Chieh-Lee Wong, Lynn Chin, Rita Yim, Paul Lee, Lester Au, Vivian LI, Man Kit Garret Leung, Wee Joo Chng, Wen Chien Chou, Hwei-Fang Tien, Cyrus Kumana, Yok Lam Kwong
Publikováno v:
HemaSphere, Vol 7, p e6159196 (2023)
Externí odkaz:
https://doaj.org/article/cb5a2839eb8846ea9ee3910ca09b0e8e
Autor:
Nicholas Mitsiades, Kenneth C. Anderson, Constantine S. Mitsiades, Paul G. Richardson, Peter O'Gorman, Martin Clynes, Leutz Buon, Teru Hideshima, Dharminder Chauhan, Nikhil C. Munshi, Noopur S. Raje, Emily Daskalaki, Elpida Charalambous, Douglas W. McMillin, Vassiliki Kotoula, Patrick J. Hayden, Melissa G. Ooi
Supplementary Data from Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a845c66dc7589f8466201841a601261
https://doi.org/10.1158/1078-0432.22439989
https://doi.org/10.1158/1078-0432.22439989
Autor:
Nicholas Mitsiades, Kenneth C. Anderson, Constantine S. Mitsiades, Paul G. Richardson, Peter O'Gorman, Martin Clynes, Leutz Buon, Teru Hideshima, Dharminder Chauhan, Nikhil C. Munshi, Noopur S. Raje, Emily Daskalaki, Elpida Charalambous, Douglas W. McMillin, Vassiliki Kotoula, Patrick J. Hayden, Melissa G. Ooi
Purpose: p53 is inactivated in many human malignancies through missense mutations or overexpression of the human homologue of Mdm2 (Hdm2), an E3 ubiquitin ligase that ubiquitinates p53, thereby promoting its proteasomal degradation. The cis-imidazoli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728045ed524eeea6ccdefabb43cb52bf
https://doi.org/10.1158/1078-0432.c.6517366.v1
https://doi.org/10.1158/1078-0432.c.6517366.v1
Autor:
Mingrui Guo, Hon Man Tim Chan, Qi-Ling Zhou, Omer An, Ying Li, Yangyang Song, Zi Hui Tan, Hui En Vanessa Ng, Philomina Sona Peramangalam, Zhi Qing Tan, Xinang Cao, Eisaku Iwanaga, Masao Matsuoka, Melissa G Ooi, Wei Ying Jen, Liang Piu Koh, Esther Chan, Lip Kun Tan, Yufen Goh, Wilson Wang, Bryan T.H. Koh, Ming Chun Chan, Melissa J. Fullwood, Wee Joo Chng, Motomi Osato, John Anto Pulikkan, Henry Yang, Leilei Chen, Daniel G. Tenen
Publikováno v:
Blood.
Adenosine to inosine (A-to-I) RNA editing, which is catalyzed by adenosine deaminases acting on RNA (ADAR) family of enzymes ADAR1 and ADAR2, has been shown to contribute to multiple cancers. However, other than chronic myeloid leukemia (CML) blast c
Autor:
Elyse A Olesinski, Karanpreet S Bhatia, Aarthi Nivasini Mahesh, Shazwina Rosli, Jameelah S Mohamed, Wei Ying Jen, Nitin Jain, Jacqueline S. Garcia, Gee Chuan Wong, Melissa G Ooi, Anthony Letai, Marina Y. Konopleva, Shruti Bhatt
Publikováno v:
Blood Advances.
Publikováno v:
International Journal of General Medicine, Vol 2009, Iss default, Pp 5-7 (2009)
Melissa G Ooi1, Peter J Kelly2, Michael Farrell3, Philip Murphy4, Peter O’Gorman11Department of Hematology; 2Department of Neurology, Mater Misericordiae Hospital, Dublin, Ireland; 3Department of Neuropathology; 4Department of Hematology, Beaumont
Externí odkaz:
https://doaj.org/article/2dfb6efa894a4891ad4d324df9fbd011
Autor:
Soumya Ojha, Melissa G Ooi
Publikováno v:
Annals of Hematology. 99:355-356
Autor:
Xiao-Shi Saw, Lon-Wann Sai, Hian Li Esther Chan, Xiaojuan Chen, Yee Mei Lee, Michelle Poon, Yen Lin Chee, Chin-Hin Ng, Shi Hui Clarice Choong, Melissa G. Ooi, Foong-Gwan Lee
Publikováno v:
Blood. 134:2152-2152
Background: High dose cytarabine (HiDAC) consolidation in AML is conventionally given in the inpatient setting over approximately 6-7 days. Patients usually tolerate this treatment uneventfully, with occasional cytarabine-related fever or rash. As th
Autor:
Steffen Klippel, Constantine S. Mitsiades, Efstathios Kastritis, Kenneth C. Anderson, Jana Jakubikova, Paul G. Richardson, Douglas W. McMillin, Melissa G. Ooi, Jacob P. Laubach, Jake Delmore
Publikováno v:
British Journal of Haematology. 159:340-351
Summary Jasmonates, plant stress hormones, have been demonstrated to be effective in killing various types of cancer cells. We therefore tested if methyljasmonate (MJ) has activity against multiple myeloma (MM) in vitro and in vivo. MM cell lines and